The Latin American flow cytometry market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022



Increasing prevalence of cancer and HIV/AIDS, growing research activities adopting flow cytometry techniques, and increasing innovation efforts to develop technologically advanced tools and software are major drivers for the growth of the Latin American Flow cytometry market.

New York, Dec. 09, 2022 (GLOBE NEWSWIRE) — released the report “Latin America Flow Cytometry Market by Technology, End User – Forecast to 2027” — p06372347/?utm_source= GNW
However, the high cost of flow cytometry products such as equipment and consumer is a major factor that is expected to restrain the market growth to some extent.
The reagents and consumables segment accounts for the largest growth rate in the Latin America Flow Cytometry market during the forecast period, in terms of products and services.
In 2021, the reagents and consumables segment has the highest growth rate. Factors such as steady demand for flow cytometry reagents for diagnostic applications and growing research activities using flow cytometry techniques are expected to favor the growth of this market.

Also Read :  GLOBAL MARKETS-Stocks rally, dollar slips as sentiment favors risk assets

Mexico: The fastest growing country in the Flow cytometry market in Latin America
The Mexican market is estimated to register the highest CAGR during the forecast period. Favorable trade agreements for the availability of flow cytometry products in the country and the growth of the pharmaceutical industry are expected to support market growth in the country.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 50% and Demand Side 50%
• By appointment: Level C (Manager) – 45%, Level D (CXO, Manager) – 30%, and Other (Manager) – 25%
• By Region – Latin America: Brazil -20%, Mexico -20%, Argentina -20%, Colombia -20%, Chile – 15%, rest of Latin America – 5%

Also Read :  USD retraces some of its recent gains as markets dial back Fed rate hike bets

List of Companies Profiled in the Report:
• Becton, Dickinson and Company (USA)
• Danaher Corporation (USA)
• Thermo Fisher Scientific, Inc. (USA)
• Agilent Technologies, Inc. (USA)
• Sony Group Corporation (Japan)
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec GmbH (Germany)
• Enzo Biochem, Inc.
• Sysmex Corporation (Japan)
• Luminex Corporation (USA)
• bioMérieux SA (France)
• Sartorius AG (Germany)
• Union Biometrica, Inc. (USA)
• Takara Bio, Inc. (Japan)
• Cytek Biosciences, Inc. (USA)
• Apogee Flow Systems Ltd. (UK)
• BioLegend, Inc. (USA)

Research Report:
This report provides a detailed picture of the Latin America Flow Cytometry Market. It aims to estimate the size and future growth potential of the market across various segments such as products and services, technology, application, end user and region.

The report also includes an in-depth competitive analysis of key market players along with their company profiles recent developments and key market strategies.

Also Read :  Global $80+ Bn Aluminum Extrusion Markets, 2016-2021,

Key Benefits of Buying a Report:
The report will help the market leaders/new entrants to provide them with the closest approximations of the revenue figures for the entire Latin America Flow Cytometry Market and its segments. It will also help participants better understand the competitive landscape and gain more insight to better position their business and create appropriate go-to-market strategies. This report will help participants understand the pulse of the market and inform them about key market drivers, challenges, restraints, trends and opportunities.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data, so you get all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001


Leave a Reply

Your email address will not be published.